Abstract
- The C7–T1 interspace is generally preferred for cervical interlaminar epidural steroid injections (ESIs) because of its relatively wide epidural space, which allows for safer needle access. However, cervical degeneration primarily occurs above the C7–T1 level, suggesting that interlaminar ESIs would be more effective at C6–C7 than at C7–T1. This report presents a case of central cervical spinal stenosis that was refractory to conventional C7–T1 interlaminar ESIs but showed significant pain relief following a targeted injection at C6–C7. A 71-year-old male presented with chronic posterior neck pain and bilateral interscapular pain (numeric rating scale [NRS] 7) associated with multilevel central canal stenosis from C3–C4 to C6–C7. The patient had previously undergone four sessions of interlaminar ESIs at the C7–T1 level, with no pain relief. Subsequently, we performed interlaminar ESI at C6–C7 to achieve better drug delivery to the stenotic segments. Following the C6–C7 injection, the patient’s pain decreased from NRS 7 to NRS 3, with sustained relief lasting for at least 2 months. When cervical ESIs at C7–T1 provide insufficient relief, interlaminar ESIs at C6–C7 may be considered an alternative approach to improve clinical outcomes.
-
Keywords: Cervical vertebrae; Epidural space; Injections; Steroids
Introduction
- Central cervical spinal stenosis is defined as narrowing of the cervical spinal canal, which can lead to chronic posterior neck pain due to mechanical compression and secondary neural inflammation [1]. Common anatomical causes include cervical disc herniation, osteophyte formation, and ossification of the posterior longitudinal ligament [2,3]. As the central canal narrows, compression of the spinal cord may occur, resulting in ischemia and triggering inflammatory cascades [4].
- Management typically begins with conservative measures including pharmacotherapy and physical therapy. If these treatments fail to provide adequate pain relief, cervical interlaminar epidural steroid injections (ESIs) may be considered [5]. Steroids injected into the epidural space exert potent anti-inflammatory effects by inhibiting the synthesis of inflammatory mediators and reducing edema in surrounding tissues. These effects help decrease the pressure on neural structures, potentially restoring neural passage and improving local ischemic conditions, which may reduce neck pain associated with central cervical spinal stenosis [6-8].
- For cervical interlaminar ESIs, the C7–T1 interspace is generally preferred because the posterior epidural space is the widest at this level, facilitating needle access and minimizing the risk of dural puncture or cord injury [9]. However, Schultz et al. indicated that injections at this level may fail to adequately target the inflamed regions in the epidural space above C7–T1 [10].
- In this report, we present a case of central cervical spinal stenosis that was refractory to conventional C7–T1 interlaminar ESIs but showed significant pain relief following a targeted injection at the C6–C7 level.
Case
-
Ethics statement: This study complied with the Declaration of Helsinki and was approved by the Institutional Review Board (IRB) of Yeungnam University Hospital (IRB No: 2026-01-002). The patient provided written informed consent for publication of this case and the accompanying clinical information.
- A 71-year-old man presented with chronic posterior neck pain that had persisted for 2 years and had worsened over the past 5 months. The pain was localized to the posterior neck and bilateral interscapular regions without radiating to the upper extremities. His numeric rating scale (NRS) score was 7 out of 10. The pain significantly impaired his daily activities and ultimately led to cessation of work. The patient had no motor weaknesses or sensory deficits in the upper or lower extremities. The biceps and triceps reflexes were normoactive. Spurling’s test and Hoffmann’s sign were negative. The patient had previously undergone four sessions of interlaminar cervical ESIs at the C7–T1 level at an outpatient clinic; however, these did not provide pain relief. Cervical magnetic resonance imaging revealed multilevel central canal stenosis from C3–C4 to C6–C7 (Fig. 1). At our hospital, we also performed cervical ESI at the C7–T1 level. Strict aseptic techniques were used throughout the procedure. The patient was placed in the prone position with a towel or blanket under the chest to ensure sufficient flexion of the cervical spine. C-arm fluoroscopy (Siemens Healthcare, Erlangen, Germany) was used for level identification and needle guidance. At the needle insertion site, 1% lidocaine was administered and a 21-gauge Tuohy needle was inserted into the epidural space between C7 and T1 using the loss-of-resistance technique. Adequate placement of the needle tip in the epidural space was confirmed by injecting a radiopaque contrast medium. After confirmation, a mixture of 20 mg of triamcinolone acetonide, 0.5 mL of 2% lidocaine, and 4 mL of normal saline was injected.
- Given the lack of response to prior epidural injections, we performed interlaminar ESI at the C6–C7 level to achieve better drug delivery to the stenotic segments (Fig. 2). The procedure was performed in the same manner as the C7–T1 injection, except for targeting the C6–C7 level. At follow-up assessments at 2 weeks, 1 month, and 2 months after the C6–C7 injection, the patient’s pain decreased from an NRS score of 7 to 3. However, by 3 months, the pain had returned to the pre-injection level (NRS 7). Repeat interlaminar ESI was performed at the C6–C7 level, after which the pain score decreased again to NRS 3. Since then, the patient has been receiving interlaminar ESIs at the C6–C7 level once every 3 to 6 months, with reproducible pain reduction following each injection.
Discussion
- We report the case of a patient with multilevel central canal stenosis from C3–C4 to C6–C7 who experienced persistent pain despite multiple interlaminar ESIs performed at the C7–T1 level. However, interlaminar ESI administered at the C6–C7 level resulted in significant pain reduction.
- The C7–T1 interspace is widely accepted as the standard access point for cervical ESIs because of its relatively large posterior epidural depth, which provides a wide safety margin for needle placement [9]. At higher cervical levels, the epidural space narrows significantly, increasing the risk of inadvertent dural puncture or direct spinal cord injury during needle advancement. Therefore, the current guidelines recommend performing cervical interlaminar ESIs at C7–T1 whenever feasible, with the C6–C7 level as an alternative when necessary [11].
- However, our patient did not respond to injections at the standard C7–T1 level. Therefore, we adopted a strategy to target the C6–C7 level, which was closer to the suspected source of pain. After interlaminar ESI at C6–C7, the patient reported a significant reduction in pain in the posterior neck and bilateral interscapular regions. These findings suggest that in selected patients who experience insufficient pain relief following an interlaminar ESI at C7–T1, a more cephalad injection level, such as C6–C7, warrants consideration. However, this observation is based on a single case and should not be interpreted as evidence of superior efficacy of the C6–C7 approach.
- In 2024, Hasoon et al. [12] reported a case in which a patient with pathology at C5–C6 and C6–C7 showed limited cephalad contrast spread following an initial injection at C7–T1. However, targeting the C6–C7 interspace resulted in improved contrast flow to the affected levels and >90% symptom relief. The authors suggested that severe central canal stenosis could act as a physical barrier, impeding cephalad migration of the injectate from the lower entry point. Similarly, in our patient, multilevel stenosis from C3–C4 to C5–C6 may have created a similar anatomical obstruction. In such cases, reducing the distance between the target lesion and the injection site using a more proximal approach significantly increases the likelihood of effective medication delivery.
- From the perspective of epidural compliance, which is defined as the ability of a structure to yield elastically in response to an applied force, anatomical variations between cervical levels may partially explain our findings. The relatively larger posterior epidural space at C7–T1 may theoretically allow greater accommodation of the injectate, whereas the narrower epidural space at C6–C7 may result in different pressure dynamics during injection. These anatomical and biomechanical considerations may influence the distribution of the injectate; however, this mechanism remains speculative in the present case because epidural pressure and contrast spread were not directly assessed [13].
- Cervical spine degeneration typically occurs above the C7–T1 level; thus, interlaminar ESIs at the C6–C7 level might be more effective in addressing the pathology in these areas. However, the posterior epidural space is narrower at C6–C7 than at C7–T1, which makes targeting the former space technically challenging. Therefore, injections at the C6–C7 level should be administered with caution under fluoroscopic guidance by an experienced physician.
- In conclusion, we present the case of a patient with central cervical spinal stenosis whose pain did not respond to interlaminar ESIs in the standard C7–T1 interspace. Clinical improvement was achieved after an injection at the C6–C7 level. This finding suggests that when cervical ESIs at C7–T1 provide insufficient relief, interlaminar ESIs at C6–C7 should be considered an alternative approach to improve clinical outcomes. However, there is a higher risk of dural puncture or spinal cord injury, and heightened attention to procedural safety is essential. This study has some limitations. First, as this was a single case report, the observed pain relief following C6–C7 interlaminar ESI cannot establish the superiority of this approach over the conventional C7–T1 approach, and the findings should be interpreted with caution. Second, we did not systematically evaluate the cephalad spread of the contrast medium during the C7–T1 or C6–C7 injections.
Article information
-
Conflicts of interest
Mathieu Boudier-Revéret and Min Cheol Chang have been editorial board members of the Journal of Yeungnam Medical Science since 2021. They were not involved in the review process of this manuscript. There are no other conflicts of interest to declare.
-
Funding
This work was supported by the National Research Foundation of Korea grant funded by the Korean government (MSIT) (No. RS-2023-00219725).
-
Use of artificial intelligence
No artificial intelligence-assisted technologies were used in the preparation of this manuscript.
-
Author contributions
Conceptualization, Methodology, Investigation: all authors; Funding acquisition, Project administration, Supervision: MCC; Writing-original draft: all authors; Writing-review & editing: all authors.
Fig. 1.Cervical spine magnetic resonance imaging. (A) Sagittal and (B–F) axial T2-weighted images demonstrating multilevel central canal stenosis from C3–C4 to C6–C7.
Fig. 2.Fluoroscopic images during interlaminar epidural steroid injection at C6–C7. (A) Lateral and (B) anteroposterior views showing epidural contrast spread.
References
- 1. Lee DG, Chang MC. Effect of interlaminar epidural steroid injection in patients with central cervical spinal stenosis. World Neurosurg 2018;109:e150–4.ArticlePubMed
- 2. Morishita Y, Naito M, Hymanson H, Miyazaki M, Wu G, Wang JC. The relationship between the cervical spinal canal diameter and the pathological changes in the cervical spine. Eur Spine J 2009;18:877–83.ArticlePubMedPMC
- 3. Stafira JS, Sonnad JR, Yuh WT, Huard DR, Acker RE, Nguyen DL, et al. Qualitative assessment of cervical spinal stenosis: observer variability on CT and MR images. AJNR Am J Neuroradiol 2003;24:766–9.PubMedPMC
- 4. Akuthota V, Lento P, Sowa G. Pathogenesis of lumbar spinal stenosis pain: why does an asymptomatic stenotic patient flare? Phys Med Rehabil Clin N Am 2003;14:17–28.ArticlePubMed
- 5. Huston CW. Cervical epidural steroid injections in the management of cervical radiculitis: interlaminar versus transforaminal. A review. Curr Rev Musculoskelet Med 2009;2:30–42.ArticlePubMedPMCPDF
- 6. Greaves MW. Anti-inflammatory action of corticosteroids. Postgrad Med J 1976;52:631–3.ArticlePubMedPMCPDF
- 7. Bernhardt M, Hynes RA, Blume HW, White AA 3rd. Cervical spondylotic myelopathy. J Bone Joint Surg Am 1993;75:119–28.ArticlePubMed
- 8. Kang Y, Lee JW, Koh YH, Hur S, Kim SJ, Chai JW, et al. New MRI grading system for the cervical canal stenosis. AJR Am J Roentgenol 2011;197:W134–40.ArticlePubMed
- 9. Benzon HT, Huntoon MA, Rathmell JP. Improving the safety of epidural steroid injections. JAMA 2015;313:1713–4.ArticlePubMed
- 10. Schultz DM, Hagedorn JM, Abd-Elsayed A, Stayner S. Safety of interlaminar cervical epidural injections: experience with 12,168 procedures in a single pain clinic. Pain Physician 2022;25:49–58.PubMed
- 11. Holder EK, Lee H, Raghunandan A, Marshall B, Michalik A, Nguyen M, et al. Factfinders for patient safety: minimizing risks with cervical epidural injections. Interv Pain Med 2024;3:100430.ArticlePubMedPMC
- 12. Hasoon J, Chu K, Chu W, Govindaraj R. Optimizing cervical epidural steroid injections: a case report. Orthop Rev (Pavia) 2024;16:124767.ArticlePubMedPMC
- 13. Bosscher H. Pressure-volume relationships in the spinal canal and potential neurological complications after epidural fluid injections. Front Pain Res (Lausanne) 2022;3:884277.ArticlePubMedPMC
Citations
Citations to this article as recorded by
